US biotechs turn secretive as they fear competition from rising Chinese industry
US biotechs turn tight-lipped on gene targets and pipelines as China's fast-follower threat intensifies, 20+ founders and investors tell Endpoints.
Read the full articleYou might also wanna read
As US lawmakers increase scrutiny of Chinese trials, industry fears ‘huge distraction and expense’
As U.S. lawmakers continue to scrutinize the consequences of China’s expanding role in biotech innovation, industry insiders have been left
China's biotech rise: A case study in multiple myeloma drug development
A drug for multiple myeloma should have been an early warning that China is racing ahead in biotech
writingruxandrabio.com·24d agoChina Criticises Proposed U.S. Chip Equipment Bill Ahead of Beijing Talks
The proposed restrictions arrive amid an already intensifying global race around AI infrastructure.
US budget slashing risks losing global scientific edge to China
Experts warn that cuts to US research funding is weakening the country’s scientific and technological capacity.
US Eyes Korean Chip Plants as China Draws AI Brains
US Commerce Secretary Lutnick urges Samsung and SK hynix to build chip plants in America as global "Fab War" intensifies, while China recrui
CNBC: The US wants to restrict corporate use of Chinese AI
US companies are increasingly turning to Chinese-made AI models to cut costs, something the government isn't happy about.
Comments
Sign in to join the conversation.
No comments yet. Be the first.